Filing Details
- Accession Number:
- 0001493152-20-016316
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-19 16:30:27
- Reporting Period:
- 2020-08-17
- Accepted Time:
- 2020-08-19 16:30:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
883975 | Microbot Medical Inc. | MBOT | Biological Products, (No Disgnostic Substances) (2836) | 943078125 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1690100 | Yoseph Bornstein | C/O Microbot Medical Inc. 25 Recreation Park Drive, Unit 108 Hingham MA 02043 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-08-17 | 15,000 | $10.18 | 287,028 | No | 4 | S | Indirect | By LSA- LifeScience Accelerator Ltd. |
Common Stock | Disposition | 2020-08-17 | 119 | $11.91 | 286,909 | No | 4 | S | Indirect | By LSA- LifeScience Accelerator Ltd. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By LSA- LifeScience Accelerator Ltd. |
No | 4 | S | Indirect | By LSA- LifeScience Accelerator Ltd. |
Footnotes
- Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 15,119 shares of Issuer common stock on August 17, 2020. Accordingly, Reporting Person beneficially owned 286,909 shares of Issuer common stock following the reported transactions.
- Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. ("LSA") and of Shizim Ltd. ("Shizim"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities.